Skip to content

Fibrinogen to Albumin Ratio (FAR) as a Predictive Biomarker for Lupus Nephritis (LN)

Fibrinogen to Albumin Ratio as a Predictive Biomarker for Lupus Nephritis (LN)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06288308
Enrollment
90
Registered
2024-03-01
Start date
2024-03-20
Completion date
2024-12-31
Last updated
2024-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lupus Nephritis

Brief summary

Fibrinogen to Albumin ratio as a predictive biomarker for lupus nephritis (LN)

Detailed description

Systemic lupus erythematosus is a chronic autoimmune disease often coexists with other diseases and damages multiple organs such as kidney liver nervous system and so on. Lupus nephritis is clinically evident in 50-60% of patients with systemic lupus erythematosus and it is histologically evident in most SLE patients even those without clinical manifestations of kidney disease . The current standardized classification system for lupus nephritis is derived from the World Health Organization and the International Society of Nephrology/Renal Pathology Society's recommendations. The classification system is based on glomerular morphologic changes seen on microscopy immune deposits seen on immunofluorescence and also electronic microscopy. Class 1 - Minimal Mesangial Lupus Nephritis. Class 2 - Mesangial Proliferative Lupus Nephritis. Class 3 - Focal Lupus Nephritis. Class 4 - Diffuse Lupus Nephritis. Class 5 - Membranous Lupus Nephritis. Class 6 - Advanced Sclerosis Lupus Nephritis. Fibrinogen (FIB) is an acute time response protein rises rapidly in inflammation infection myocardial infarction and tumor. The formation and deposition of immune complexes are important mechanism of lupus nephritis the infiltrate of inflammatory cells and the release of inflammatory factors cause renal injury resulting in the decreasing concentration of albumin. The fibrinogen-to-albumin ratio as a new inflammatory marker has been proved to have good predictive value in the diagnosis and prognosis of diabetic nephropathy acute renal injury SLE disease and so on.

Interventions

DIAGNOSTIC_TESTfibronigin to albumin ratio

To investigate the association of fibrinogen to albumin ratio (FAR) with LN in different classes. b. Secondary (subsidiary): To prove the possible role of FAR as a novel diagnostic biomarker to predict LN progression

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years

Inclusion criteria

1. 90 Pts with SLE that have LN in different classes. 2. Age between 18-60 yrs.

Exclusion criteria

1. Pts with ESRD, manifested cardiac valvular disease, acute infection, history of hepatitis, pts with DM and Cancer. 2. Age below 18 yrs& above 60 yrs 3. Pt who refused to contribute in this study

Design outcomes

Primary

MeasureTime frameDescription
Fibrinogen to Albumin ratio as a predictive biomarker for lupus nephritis (LN)1 yearinvestigate the association of fibrinogen to albumin ratio (FAR) with LN and to prove its possible role as a novel biomarker to predict LN progression

Contacts

Primary ContactAhmed Mamdouh
ahmedfares1995mm@gmail.com01154226730
Backup Contactmohamed hassan
moh_has_mos@yahoo.com01030430421

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026